UBS Group’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-1,129
| Closed | -$1K | – | 10271 |
|
2021
Q4 | $1K | Buy |
+1,129
| New | +$1K | ﹤0.01% | 9065 |
|
2021
Q3 | – | Sell |
-3,834
| Closed | -$9K | – | 9477 |
|
2021
Q2 | $9K | Buy |
+3,834
| New | +$9K | ﹤0.01% | 7108 |
|
2020
Q4 | – | Sell |
-18,566
| Closed | -$43K | – | 8024 |
|
2020
Q3 | $43K | Buy |
+18,566
| New | +$43K | ﹤0.01% | 4916 |
|
2020
Q2 | – | Sell |
-245
| Closed | – | – | 7659 |
|
2020
Q1 | $0 | Buy |
+245
| New | – | ﹤0.01% | 7599 |
|
2019
Q4 | – | Sell |
-2,954
| Closed | -$9K | – | 7523 |
|
2019
Q3 | $9K | Sell |
2,954
-1,724
| -37% | -$5.25K | ﹤0.01% | 6286 |
|
2019
Q2 | $19K | Buy |
4,678
+1,577
| +51% | +$6.41K | ﹤0.01% | 5800 |
|
2019
Q1 | $15K | Sell |
3,101
-238
| -7% | -$1.15K | ﹤0.01% | 5737 |
|
2018
Q4 | $8K | Buy |
3,339
+2,587
| +344% | +$6.2K | ﹤0.01% | 6459 |
|
2018
Q3 | $5K | Buy |
752
+595
| +379% | +$3.96K | ﹤0.01% | 6610 |
|
2018
Q2 | $1K | Buy |
+157
| New | +$1K | ﹤0.01% | 6961 |
|
2018
Q1 | – | Sell |
-803
| Closed | -$7K | – | 7236 |
|
2017
Q4 | $7K | Buy |
803
+93
| +13% | +$811 | ﹤0.01% | 6291 |
|
2017
Q3 | $8K | Buy |
710
+437
| +160% | +$4.92K | ﹤0.01% | 6116 |
|
2017
Q2 | $11K | Sell |
273
-407
| -60% | -$16.4K | ﹤0.01% | 5799 |
|
2017
Q1 | $33K | Buy |
680
+32
| +5% | +$1.55K | ﹤0.01% | 4897 |
|
2016
Q4 | $21K | Sell |
648
-60
| -8% | -$1.94K | ﹤0.01% | 5553 |
|
2016
Q3 | $29K | Buy |
708
+483
| +215% | +$19.8K | ﹤0.01% | 5106 |
|
2016
Q2 | $7K | Sell |
225
-46
| -17% | -$1.43K | ﹤0.01% | 6103 |
|
2016
Q1 | $17K | Buy |
271
+46
| +20% | +$2.89K | ﹤0.01% | 5497 |
|
2015
Q4 | $9K | Sell |
225
-194
| -46% | -$7.76K | ﹤0.01% | 6080 |
|
2015
Q3 | $23K | Buy |
419
+31
| +8% | +$1.7K | ﹤0.01% | 5357 |
|
2015
Q2 | $43K | Buy |
+388
| New | +$43K | ﹤0.01% | 4878 |
|
2015
Q1 | – | Sell |
-146
| Closed | -$8K | – | 6913 |
|
2014
Q4 | $8K | Buy |
+146
| New | +$8K | ﹤0.01% | 6149 |
|